StockNews.com began coverage on shares of NantHealth (NASDAQ:NH – Get Rating) in a report published on Wednesday morning. The brokerage issued a hold rating on the stock.
NantHealth Price Performance
NantHealth stock opened at $3.46 on Wednesday. NantHealth has a one year low of $1.57 and a one year high of $15.75. The stock's 50 day moving average is $2.59 and its 200 day moving average is $1.16. The firm has a market cap of $26.68 million, a P/E ratio of -0.45 and a beta of 1.88.
Get NantHealth alerts:NantHealth (NASDAQ:NH – Get Rating) last released its quarterly earnings data on Thursday, November 3rd. The company reported ($0.13) EPS for the quarter. The firm had revenue of $16.63 million during the quarter.
Institutional Investors Weigh In On NantHealth
Several institutional investors have recently bought and sold shares of the stock. Goldman Sachs Group Inc. bought a new position in NantHealth during the 2nd quarter worth approximately $36,000. Hartline Investment Corp purchased a new position in shares of NantHealth in the second quarter valued at about $65,000. Millennium Management LLC purchased a new position in shares of NantHealth in the second quarter valued at about $110,000. Finally, Atria Wealth Solutions Inc. purchased a new position in shares of NantHealth in the first quarter valued at about $170,000. Institutional investors own 4.50% of the company's stock.NantHealth Company Profile
(Get Rating)
NantHealth, Inc is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment.
Featured Articles
- Get a free copy of the StockNews.com research report on NantHealth (NH)
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- Ford Stock Going Forward After Big Earnings Flop
- Insiders And Institutions Buy Wolverine Worldwide
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.